CD96 co-expression with CD226 was also significantly more frequent in cells from the blood than from the tumour (>3-fold mean difference in all subsets) and rare in tumours (Highest mean frequency of 7.3% ±1.4% in non-Treg CD4 + T cells; Supplementary Fig. 2b, c). The gene discussed is CD4; the disease is neoplasm.